![Iris Löw-Friedrich](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 215 653 $ in data 31/05/2026
La dottoressa Iris Lw-Friedrich è vicepresidente del consiglio di sorveglianza di Evotec SE, Chief Medical Officer & Executive Vice President di UCB SA e professore alla Johann Wolfgang Goethe-Universitt Frankfurt am Main. Fa parte del Consiglio di amministrazione di Fresenius SE & Co. KGaA e Evotec SE. La dottoressa Lw-Friedrich è stata precedentemente impiegata come presidente di Transcelerate Biopharma, Inc., membro del consiglio di sorveglianza di Heidelberg Pharma AG, direttore di ricerca e sviluppo di UCB Pharma GmbH, vicepresidente dei progetti globali di BASF Pharma, vicepresidente dei progetti globali di BASF AG, vicepresidente dello sviluppo clinico di Hoechst AG, responsabile della gestione clinica globale e vicepresidente di Aventis Pharma AG e vicepresidente dello sviluppo clinico di Hoechst Marion Roussel, Inc. Ha ricevuto il suo dottorato dalla Johann Wolfgang Goethe-Universitt Frankfurt am Main.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
EVOTEC SE 0,02% | 31/12/2025 | 35.000 ( 0,02% ) | 215 653 $ | 31/05/2026 |
| 30/01/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| FRESENIUS SE & CO. KGAA | Direttore/Membro del Consiglio | 13/05/2016 |
| SWEDISH ORPHAN BIOVITRUM AB | Direttore/Membro del Consiglio | 08/05/2025 |
| SATELLOS BIOSCIENCE INC. | Direttore/Membro del Consiglio | 18/06/2025 |
| FINANCIÈRE DE TUBIZE S.A. | Direttore/Membro del Consiglio | 24/09/2025 |
| BIONTECH SE | Direttore/Membro del Consiglio | 15/05/2026 |
Celosia Therapeutics Pty Ltd.
 Celosia Therapeutics Pty Ltd. BiotechnologyHealth Technology Operates as a biotechnology company which uses gene therapy to treat neurodegenerative diseases | Presidente | - |
PhRMA Foundation
 PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services Engages in research and development of drugs | Direttore/Membro del Consiglio | 01/04/2019 |
Johann Wolfgang Goethe-Universität Frankfurt am Main
 Johann Wolfgang Goethe-Universität Frankfurt am Main Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2000 |
| Società | Posizione | Fine |
|---|---|---|
| EVOTEC SE | Presidente | 11/06/2026 |
| ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 20 |
|---|---|
Fresenius SE & Co. KGaA
 Fresenius SE & Co. KGaA Hospital/Nursing ManagementHealth Services Develops and manufactures generic drugs, biopharmaceuticals, infusion & nutrition therapies and medical devices | Health Services |
Hoechst AG
 Hoechst AG Chemicals: Major DiversifiedProcess Industries Produces specialty chemicals and pharmaceutical products | Process Industries |
BASF SE
 BASF SE Chemicals: SpecialtyProcess Industries Manufactures plastic materials, precursors, chemicals for batteries, automotive OEM coatings, petrochemicals, intermediates, agrochemicals, industrial, nutrition & care additives | Process Industries |
UCB Pharma GmbH
 UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
Zogenix, Inc.
 Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets medicines | Health Technology |
UCB SA
 UCB SA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Evotec SE
 Evotec SE Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
Heidelberg Pharma AG
 Heidelberg Pharma AG Pharmaceuticals: MajorHealth Technology Develops cancer therapies | Health Technology |
Financière de Tubize SA
 Financière de Tubize SA Financial ConglomeratesFinance Operates as an investment holding company which invests in the chemical, pharmaceutical and film sectors | Finance |
Johann Wolfgang Goethe-Universität Frankfurt am Main
Johann Wolfgang Goethe-Universität Frankfurt am Main Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aventis Pharma AG | |
Hoechst Marion Roussel, Inc.
 Hoechst Marion Roussel, Inc. Pharmaceuticals: GenericHealth Technology Develops, manufactures and sells generic pharmaceutical products | Health Technology |
BioNTech SE
 BioNTech SE BiotechnologyHealth Technology Develops immunotherapies and mRNA-based vaccines to treat cancer & infectious diseases | Health Technology |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
BASF Pharma | |
PhRMA Foundation
PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services Engages in research and development of drugs | Commercial Services |
Transcelerate Biopharma, Inc.
 Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Provides biopharmaceutical research services | Health Technology |
Satellos Bioscience, Inc.
 Satellos Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company, which is focused on the identification, development and commercialization of drug candidates | Health Technology |
Frankfurt University Medical School
 Frankfurt University Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celosia Therapeutics Pty Ltd.
Celosia Therapeutics Pty Ltd. BiotechnologyHealth Technology Operates as a biotechnology company which uses gene therapy to treat neurodegenerative diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
